BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 46 filers reported holding BIOTA PHARMACEUTIALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $40,000 | -79.7% | 16,053 | -76.7% | 0.00% | -81.2% |
| Q2 2014 | $197,000 | -86.5% | 68,964 | -71.2% | 0.02% | -83.5% |
| Q1 2014 | $1,461,000 | +1471.0% | 239,068 | +982.7% | 0.10% | +2325.0% |
| Q4 2013 | $93,000 | -12.3% | 22,081 | -13.2% | 0.00% | -20.0% |
| Q3 2013 | $106,000 | -28.9% | 25,428 | -41.2% | 0.01% | -16.7% |
| Q2 2013 | $149,000 | – | 43,214 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 1,407,700 | $3,153,000 | 0.92% |
| Broadfin Capital, LLC | 5,223,422 | $11,700,000 | 0.51% |
| Avoro Capital Advisors LLC | 258,586 | $579,000 | 0.39% |
| RA Capital Management | 1,378,770 | $3,088,000 | 0.33% |
| BVF INC/IL | 435,900 | $976,000 | 0.19% |
| Dominick & Dominick LLC | 150,166 | $336,000 | 0.17% |
| TOWERVIEW LLC | 160,000 | $358,000 | 0.16% |
| KNOTT DAVID M | 268,327 | $601,052,000 | 0.14% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 292,807 | $656,000 | 0.09% |
| Baker Brothers Advisors | 1,106,910 | $2,479,000 | 0.02% |